BLUESTAR ADISSEO COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.27 CNY | -2.52% |
|
+0.76% | +15.88% |
| 04-25 | Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-25 | Bluestar Adisseo Company announced that it expects to receive CNY 3 billion in funding | CI |
Chart calendar Bluestar Adisseo Company
a3.AUx_nRIlzNUZwOyKBURjvtsjV9tOsKDzFi5OZhWzVlw.WCkG01lctYcumKWnXB0a9-97A5IP6cWbQ2wlPyfAZTZFfDjLKkGokkiMiw~71c7f1bb10df177e535ce65d591bdb60
Upcoming events on Bluestar Adisseo Company
Past events on Bluestar Adisseo Company
| 25/04/2024 | Q1 2024 Earnings Release |
| 28/03/2024 | Q4 2023 Earnings Release |
| 11/12/2023 08:00 | Extraordinary Shareholders Meeting |
| 27/10/2023 | Q3 2023 Earnings Release |
| 26/07/2023 | Q2 2023 Earnings Release (Projected) |
| 31/05/2023 07:30 | Annual General Meeting |
| 26/04/2023 | Q1 2023 Earnings Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 27/10/2022 | Q3 2022 Earnings Release |
| 28/07/2022 | Interim 2022 Earnings Release |
| 16/05/2022 07:30 | Extraordinary Shareholders Meeting |
| 29/04/2022 07:30 | Annual General Meeting |
| 28/04/2022 | Q1 2022 Earnings Release |
| 30/03/2022 | FY 2021 Earnings Release |
| 28/10/2021 | Q3 2021 Earnings Release |
| 22/09/2021 | Extraordinary Shareholders Meeting |
| 30/07/2021 | Interim 2021 Earnings Release |
| 17/05/2021 07:30 | Annual General Meeting |
| 29/04/2021 | Q1 2021 Earnings Release |
| 30/03/2021 | FY 2020 Earnings Release |
Past dividends on Bluestar Adisseo Company
| 12/07/2023 | Annual 0.151 CNY |
| 19/06/2022 | Annual 0.178 CNY |
| 16/06/2021 | Annual 0.176 CNY |
| 11/06/2020 | Final Payment 0.156 CNY |
| 18/12/2019 | Interim Payment 0.103 CNY |
| 12/06/2019 | Annual 0.173 CNY |
| 12/06/2018 | Annual 0.173 CNY |
| 13/06/2017 | Final Payment 0.228 CNY |
| 07/06/2016 | Interim Payment 0.165 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 11 135 11 649 -4.41% | 11 910 12 635 -5.74% | 12 869 13 313 -3.34% | 14 529 14 713 -1.25% | 13 184 14 293 -7.76% | 15 168 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 0,00 - | 3 164 3 134 0.97% | 3 200 3 429 -6.67% | 2 931 3 210 -8.69% | 1 669 2 324 -28.21% | 2 730 |
|
EBIT Million CNY | Released Forecast Spread | 1 589 1 980 -19.75% | 2 046 2 207 -7.28% | 2 082 2 351 -11.45% | 1 503 2 083 -27.86% | 68,4 1 552 -95.59% | 1 244 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 0,00 - | 1 998 2 273 -12.08% | 0,00 0,00 - | 1 541 2 035 -24.28% | 64,4 249 -74.11% | 1 146 |
|
Net income Million CNY | Released Forecast Spread | 0,00 0,00 - | 1 352 1 615 -16.27% | 0,00 0,00 - | 1 247 1 461 -14.67% | 52,2 167 -68.67% | 865 |
|
EPS CNY | Released Forecast Spread | 0,00 0,00 - | 0,50 0,55 -9.44% | 0,55 0,55 -0.7% | 0,46 0,55 -15.86% | 0,02 0,06 -67.97% | 0,32 |
| Announcement Date | 13/02/20 | 10/02/21 | 30/03/22 | 15/02/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 3 605 3 402 5.96% | 3 729 3 375 10.49% | 7 334 7 471 -1.84% | 3 152 3 454 -8.74% | 3 176 4 025 -21.07% | 3 286 3 380 -2.8% | 3 569 3 048 17.12% | 6 855 6 852 0.05% | 3 496 3 538 -1.21% | 3 970 | 8 314 | 3 800 | 3 416 | 7 299 | 8 232 | 8 232 |
|
EBITDA Million CNY | Released Forecast Spread | 590 811 -27.17% | 927 | 764 | 838 | 518 | 604 | 616 | 645 | 677 | 573 | ||||||
|
EBIT Million CNY | Released Forecast Spread | 358 536 -33.1% | 30,0 542 -94.47% | 388 984 -60.51% | 19,1 452 -95.77% | 43,1 526 -91.81% | 1 410 206 585.4% | 80,1 292 -72.6% | 6,15 | 367 280 30.95% | 309 | 1 048 | 342 | 237 | 271 | 554 | 554 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 17,2 434 -96.05% | 38,0 507 -92.52% | -73,2 200 -136.6% | 82,5 273 -69.8% | 359 266 35.18% | 295 | 347 | 177 | ||||||||
|
Net income Million CNY | Released Forecast Spread | 1,49 338 -99.56% | 31,9 396 -91.94% | -67,8 158 -142.94% | 86,6 204 -57.54% | 277 199 38.88% | 221 | 260 | 125 | ||||||||
|
EPS CNY | Released Forecast Spread | 0,11 0,15 -27.51% | 0,03 0,12 -74.36% | 0,00 0,13 -99.52% | 0,01 0,15 -93.63% | -0,02 0,06 -133.97% | 0,03 0,08 -60.54% | 0,01 0,01 0% | 0,10 0,07 34.52% | 0,08 | 0,32 | 0,10 | 0,05 | 0,03 | 0,14 | 0,14 | |
| Announcement Date | 27/10/22 | 15/02/23 | 15/02/23 | 26/04/23 | 04/08/23 | 27/10/23 | 28/03/24 | 28/03/24 | 25/04/24 | - | - | - | - | - | - | - |
| 28/04/2024 | VETOQUINOL SA: Q1 2024 Sales and Revenue Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 02/05/2024 06:45 | VIMIAN GROUP AB: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | ZOETIS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ELANCO ANIMAL HEALTH INCORPORATED: Q1 2024 Earnings Release |
| 07/05/2024 | PHIBRO ANIMAL HEALTH CORPORATION: Q3 2024 Earnings Release |
| 15/07/2024 | VIRBAC: Q2 2024 Sales and Revenue Release |
| 24/07/2024 | SWEDENCARE AB: Q2 2024 Earnings Release |
Past sector events for Bluestar Adisseo Company
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600299 Stock
- Calendar Bluestar Adisseo Company
